Do you want to read an article? Please log in or register.
Opicapone for the treatment of Parkinson's disease: A review of a new licensed medicine
Parkinson’s Disease
Related content
RECOMMENDED
Parkinson’s Disease
Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review
Mov Disord.
Seppi K, Ray Chaudhuri K, Coelho M, Fox SH, Katzenschlager R, Perez Lloret S, Weintraub D, Sampaio C, and the collaborators of the Parkinson's Disease Update on Non-Motor Symptoms Study Group on behalf of the Movement Disorders Society Evidence-Based Medicine Committee
doi: 10.1002/mds.27602.
RECOMMENDED
Parkinson’s Disease
Diagnosis and Treatment of Parkinson Disease: A Review
★ 2
Recommended by
Prof. Dr Claudio Gobbi, Faculty Member
JAMA.
Armstrong MJ, Okun MS
doi: 10.1001/jama.2019.22360.
Effectiveness of opicapone and switching from entacapone in fluctuating Parkinson disease
Neurology.
Ferreira JJ, Lees AJ, Poewe W, Rascol O, Rocha JF, Keller B, Soares-da-Silva P
doi: 10.1212/WNL.
Opicapone: A Review in Parkinson's Disease
Drugs.
Scott LJ
doi: 10.1007/s40265-016-0623-y.
Recommendations for the Treatment of Patients With Parkinson Disease During Ramadan.
JAMA Neurol.
Damier P, Al-Hashel J
doi: 10.1001/jamaneurol.
Surgical management of camptocormia in Parkinson's disease: systematic review and meta-analysis
J Neurosurg.
Chan AK, Chan AY, Lau D, Durcanova B, Miller CA, Larson PS, Starr PA, Mummaneni PV
doi: 10.3171/2018.4.JNS173032.
Aging and Cognitive FunctionsParkinson’s Disease
Caffeine as symptomatic treatment for Parkinson disease (Café-PD): A randomized trial
Neurology.
Postuma RB, Anang J, Pelletier A, Joseph L, Moscovich M, Grimes D, Furtado S, Munhoz RP, Appel-Cresswell S, Moro A, Borys A, Hobson D, Lang AE
doi: 10.1212/
Safinamide for the treatment of Parkinson's disease
Expert Opin Pharmacother.
Scott RM, Schapira A
doi: 10.1080/
COMMENTED
Multiple Sclerosis
Genome-wide Pleiotropy Between Parkinson Disease and Autoimmune Diseases
Read the related editorial recommended by Dr med. Andreas Hottinger:
Parkinson Disease and Autoimmune Disorders-What Can We Learn From Genome-wide Pleiotropy?
doi: 10.1001/